Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Ponsioen, A. Bohnen, P. Dekhuijzen (2005)
Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants.American journal of respiratory and critical care medicine, 172 7
P. Qaqundah, R. Sugerman, E. Ceruti, J. Maspero, J. Kleha, C. Scott, Wei Wu, R. Mehta, C. Crim (2006)
Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study.The Journal of pediatrics, 149 5
K. Carlsen, S. Stick, W. Kamin, I. Cīrule, S. Hughes, C. Wixon (2005)
The efficacy and safety of fluticasone propionate in very young children with persistent asthma symptoms.Respiratory medicine, 99 11
R. Wood (1996)
ASTHMA AND WHEEZING IN THE FIRST SIX YEARS OF LIFEPediatrics
C. Robertson, D. Price, R. Henry, C. Mellis, N. Glasgow, D. Fitzgerald, Amanda Lee, J. Turner, Melissa Sant (2007)
Short-course montelukast for intermittent asthma in children: a randomized controlled trial.American journal of respiratory and critical care medicine, 175 4
(1992)
A community - based study of the epidemiology of asthma
D. Straub, S. Minocchieri, A. Moeller, J. Hamacher, J. Wildhaber (2005)
The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old.Chest, 127 2
A. Moeller, P. Franklin, G. Hall, S. Turner, D. Straub, J. Wildhaber, S. Stick (2004)
Inhaled fluticasone dipropionate decreases levels of nitric oxide in recurrenty wheezy infantsPediatric Pulmonology, 38
N. Ostrom, B. DeCotiis, W. Lincourt, L. Edwards, K. Hanson, J. Rosenzweig, C. Crim (2005)
Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.The Journal of pediatrics, 147 2
H. Bisgaard, D. Allen, J. Milanowski, I. Kalev, L. Willits, P. Davies (2004)
Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing.Pediatrics, 113 2
A. Teper, C. Kofman, G. Szulman, S. Vidaurreta, A. Maffey (2005)
Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma.American journal of respiratory and critical care medicine, 171 6
T. Guilbert, W. Morgan, R. Zeiger, D. Mauger, S. Boehmer, S. Szefler, L. Bacharier, R. Lemanske, R. Strunk, D. Allen, G. Bloomberg, G. Heldt, M. Krawiec, G. Larsen, A. Liu, V. Chinchilli, C. Sorkness, L. Taussig, F. Martinez (2006)
Long-term inhaled corticosteroids in preschool children at high risk for asthma.The New England journal of medicine, 354 19
B. Knorr, Luis Franchi, Hans Bisgaard, Jan Vermeulen, Peter Lesouef, N. Santanello, T. Michele, Theodore Reiss, Ha Nguyen, Donna Bratton (2001)
Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.Pediatrics, 108 3
N. Johnston, P. Mandhane, J. Dai, J. Duncan, J. Greene, K. Lambert, M. Sears (2007)
Attenuation of the September Epidemic of Asthma Exacerbations in Children: A Randomized, Controlled Trial of Montelukast Added to Usual TherapyPediatrics, 120
This describes the first trial examining the efficacy of ICS and LTRA head-to-head in preschool children with asthma
J. Moorman, Rose Rudd, Carol Johnson, M. King, P. Minor, C. Bailey, Marissa Scalia, Lara Akinbami (2007)
National surveillance for asthma--United States, 1980-2004.Morbidity and mortality weekly report. Surveillance summaries, 56 8
M. García, U. Wahn, L. Gilles, A. Swern, C. Tozzi, P. Polos (2005)
Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC StudyPediatrics, 116
Montelukast added to usual asthma therapy during the September 'epidemic' was associated with reductions in days with worsening asthma symptoms and unscheduled office visits
Hofhuis (2005)
Efficacy of fluticasone propionate on lung function and symptoms in wheezy infantsAm J Respir Crit Care Med, 171
Daniel Straub, Alexander Moeller, S. Minocchieri, Juerg Hamacher, F. Sennhauser, Graham Hall, Johannes Wildhaber (2005)
The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthmaEuropean Respiratory Journal, 25
F. Martinez, A. Wright, L. Taussig, C. Holberg, M. Halonen, W. Morgan (1995)
Asthma and wheezing in the first six years of life. The Group Health Medical Associates.The New England journal of medicine, 332 3
Updated statistics reflect the multiple elements of asthma burden in the United States
Montelukast therapy for 4 weeks was associated with a significant improvement in bronchial hyperresponsiveness to methacholine relative to placebo
H. Bisgaard (2005)
Montelukast for Viral Respiratory Infection–induced Exacerbations of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 172
R. Zeiger, S. Szefler, B. Phillips, M. Schatz, F. Martinez, V. Chinchilli, R. Lemanske, R. Strunk, G. Larsen, J. Spahn, L. Bacharier, G. Bloomberg, T. Guilbert, G. Heldt, W. Morgan, M. Moss, C. Sorkness, L. Taussig (2006)
Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.The Journal of allergy and clinical immunology, 117 1
F. Hakim, D. Vilozni, A. Adler, G. Livnat, A. Tal, L. Bentur (2007)
The effect of montelukast on bronchial hyperreactivity in preschool children.Chest, 131 1
S. Szefler, J. Baker, T. Uryniak, M. Goldman, P. Silkoff (2007)
Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.The Journal of allergy and clinical immunology, 120 5
R. Wasserman, J. Baker, Kenneth Kim, K. Blake, C. Scott, Wei Wu, M. Faris, C. Crim (2006)
Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 96 6
J. Kemp, David Skoner, S. Szefler, K. Walton-Bowen, M. Cruz-Rivera, J. Smith (1999)
Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 83 3
J. Baker, M. Mellon, J. Wald, M. Welch, M. Cruz-Rivera, K. Walton-Bowen (1999)
A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants.Pediatrics, 103 2
C. Sorkness, R. Lemanske, D. Mauger, S. Boehmer, V. Chinchilli, F. Martinez, R. Strunk, S. Szefler, R. Zeiger, L. Bacharier, G. Bloomberg, R. Covar, T. Guilbert, G. Heldt, G. Larsen, M. Mellon, W. Morgan, M. Moss, J. Spahn, L. Taussig (2007)
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.The Journal of allergy and clinical immunology, 119 1
A double-blind placebo-controlled trial demonstrated efficacy of fluticasone propionate relative to placebo in 2-4-year old children with asthma
S. Szefler, B. Phillips, F. Martinez, V. Chinchilli, R. Lemanske, R. Strunk, R. Zeiger, G. Larsen, J. Spahn, L. Bacharier, G. Bloomberg, T. Guilbert, G. Heldt, W. Morgan, M. Moss, C. Sorkness, L. Taussig (2005)
Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.The Journal of allergy and clinical immunology, 115 2
MMWR Surveillance Summaries, 56
Management of asthma in preschool children with inhaled corticosteroids and leukotriene receptor antagonists Leonard B. Bacharier Department of Pediatrics, Division of Allergy and Purpose of review Pulmonary Medicine, Washington University School of The aim of this article is to review the recently published studies addressing various Medicine and St. Louis Children’s Hospital, St. Louis, Missouri, USA treatment approaches for asthma in preschool children. Recent findings Correspondence to Leonard B. Bacharier, MD, Associate Professor of Pediatrics, Washington The heterogeneity of wheezing in the preschool years complicates the study of asthma University School of Medicine, Department of in this age group. Once children at highest risk for persistence of wheezing are Pediatrics, Division of Allergy and Pulmonary Medicine, St. Louis Children’s Hospital, One Children’s Place, identified, various management strategies may be thoroughly studied. Several recent St. Louis, MO 63110, USA studies have confirmed the efficacy and safety of both inhaled corticosteroids and Tel: +1 314 454 2694; fax: +1 314 454 2515; e-mail: Bacharier_L@kids.wustl.edu leukotriene receptor antagonists in the management of early childhood asthma. In addition to examining clinical efficacy, studies investigating the effects of these Current Opinion in Allergy and Clinical treatment modalities on the underlying airway inflammation have recently
Current Opinion in Allergy and Clinical Immunology – Wolters Kluwer Health
Published: Apr 1, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.